Embecta Corp. Overview

Embecta Corp., a health care company headquartered in Franklin Lakes, United States, specializes in the provision of medical supplies and equipment. The company’s primary focus is on diabetes medication monitoring and delivery equipment, serving a global customer base. Embecta Corp. is listed on the Nasdaq stock exchange, and more information about the company can be found on its official website, www.embecta.com .

Financial Highlights

As of May 6, 2025, Embecta Corp.’s stock closed at $12.47. Over the past year, the company’s stock has experienced significant fluctuations, reaching a 52-week high of $21.48 on December 1, 2024, and a 52-week low of $10.83 on April 20, 2025. The company’s market capitalization stands at approximately $713.89 million USD.

Earnings and Valuation

Embecta Corp. has a price-to-earnings (P/E) ratio of 12.25, indicating the market’s valuation of the company relative to its earnings. This metric is often used by investors to assess the company’s financial health and growth potential.

Conclusion

Embecta Corp. continues to play a significant role in the health care sector, particularly in the niche of diabetes care. With its global reach and focus on innovative medical equipment, the company remains a key player in the industry. Investors and stakeholders will likely keep a close watch on its financial performance and market developments in the coming months.